Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001485632 | SCV001690074 | likely benign | Immunodeficiency | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004037253 | SCV003546307 | uncertain significance | not specified | 2021-12-20 | criteria provided, single submitter | clinical testing | The c.3073A>T (p.T1025S) alteration is located in exon 13 (coding exon 13) of the NFAT5 gene. This alteration results from a A to T substitution at nucleotide position 3073, causing the threonine (T) at amino acid position 1025 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003883665 | SCV004700595 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing |